Reduced trypsin binding capacity of α2-macroglobulin in diabetes
- 21 January 1986
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 154 (2) , 85-101
- https://doi.org/10.1016/0009-8981(86)90001-x
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- In vitro preparation of nonenzymatically glucosylated human transferrin, alpha 2-macroglobulin, and fibrinogen with preservation of functionDiabetes, 1985
- Glycosylation of human abumin in diabetes mellitus: Extensive microheterogeneity of serum and urinary species as revealed by isoelectric focusingElectrophoresis, 1984
- Effect of protease binding by .alpha.2-macroglobulin on intrinsic fluorescenceBiochemistry, 1982
- Mechanism of proteinase complex formation with α2‐macroglobulinFEBS Letters, 1981
- Proteolytic cleavage sites on α2-macroglobulin resulting in proteinase binding are different for trypsin and staphylococcus aureus V-8 proteinaseBiochemical and Biophysical Research Communications, 1981
- A thiol‐ester in α2‐macroglobulin cleaved during proteinase complex formationFEBS Letters, 1980
- Serum alpha 2-macroglobulin levels in diabetes.Journal of Clinical Pathology, 1980
- Blood glycoprotein levels in diabetes mellitusDiabetologia, 1976
- Diabetic retinopathy and the fibrinolytic systemDiabetes, 1975
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970